FDA Moves To Improve In Wake Of Safety Scrutiny
But Natasha Leskovsek, special counsel with Heller Ehrman, wondered if the introduction of legislation regarding drug safety is not a case of the cart pulling the horse. “Since Vioxx, the pendulum at the FDA has swung.” In some ways, she said, the legislation would...
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login